The proposed rule for U.S. clinical trial registration and results submission
about
Clinical trial registration, reporting, publication and FDAAA compliance: a cross-sectional analysis and ranking of new drugs approved by the FDA in 2012Guidelines for the Reporting of Treatment Trials for Alcohol Use DisordersFrom Protocols to Publications: A Study in Selective Reporting of Outcomes in Randomized Trials in OncologyAgreements and Discrepancies between FDA Reports and Journal Papers on Biologic Agents Approved for Rheumatoid Arthritis: A Meta-Research ProjectTrends in global clinical trial registration: an analysis of numbers of registered clinical trials in different parts of the world from 2004 to 2013HEDD: the human epigenetic drug databaseJournal editors impasse with outcome reporting bias.Previously unidentified duplicate registrations of clinical trials: an exploratory analysis of registry data worldwide.ClinicalTrials.gov and Drugs@FDA: A Comparison of Results Reporting for New Drug Approval Trials.Trial Reporting in ClinicalTrials.gov - The Final RuleModified Regulatory Pathways to Approve Generic Drugs in the US and a Systematic Review of Their Outcomes.The evolution in registration of clinical trials: a chronicle of the historical calls and current initiatives promoting transparency.The Mass Production of Redundant, Misleading, and Conflicted Systematic Reviews and Meta-analyses.Pharmaceutical Benefit-Risk Communication Tools: A Review of the Literature.Reporting quality and risk of bias in randomised trials in health professions education.Control of false positives in randomized phase III clinical trials.Academic clinical research: Death by a thousand clicks.Outcome reporting bias in randomized-controlled trials investigating antipsychotic drugsEminence or Evidence? The Volatility, Uncertainty, Complexity, and Ambiguity in Healthcare.Measuring clinical trial transparency: an empirical analysis of newly approved drugs and large pharmaceutical companies.A systematic review of outcomes in postoperative pain studies in paediatric and adolescent patients: towards development of a core outcome set.Factors associated with reporting results for pulmonary clinical trials in ClinicalTrials.gov.Clinical trial transparency update: an assessment of the disclosure of results of company-sponsored trials associated with new medicines approved in Europe in 2013.Does information from ClinicalTrials.gov increase transparency and reduce bias? Results from a five-report case series.Clinical Trial Registration.Sponsorship, conflict of interest, risk of bias, and reporting of participant's flow and baseline demographic information in studies applicable to the federal law to post the results in clinicaltrials.gov.Reporting bias in the literature on the associations of health-related behaviors and statins with cardiovascular disease and all-cause mortality.An audit to evaluate an institute's lead researchers' knowledge of trial registries and to investigate adherence to data transparency issues in an Italian research institute registry
P2860
Q26777323-49247957-F483-457A-923B-A08432969939Q26779440-294F5C1B-8DAA-4B47-B0C8-8276A0F9E042Q26797522-52EB0144-B66A-4FFC-AF3F-8237F00606BBQ28552773-5DFD4769-F642-4824-9330-B57D56BE42D8Q28606883-296DEB48-F767-41AF-9C97-6E9FD3028B78Q28818364-23D7D7C8-4033-440E-8AF2-0C893D4FADCFQ30488075-8FBC3324-3B4C-4A73-873D-CA533BFE725EQ31115101-CC95F147-64E6-4D09-8978-48216C3D5134Q36050268-7F7D2E60-90EC-489A-9598-5B87B817B061Q36135433-F9DA1DF4-9398-4EED-8249-ACEB4A4D7730Q38395871-91E5BF9C-4567-4B66-B524-B6F6F8BE731AQ38560675-1E5D1F06-6B12-4CF5-94F8-9B7C295760EEQ38952676-0ECC8394-505A-442A-8526-9BF238664004Q38981425-FFA5476C-DA93-4D28-9077-F35018705628Q39095990-B4B96F63-2B07-477D-B046-ED3CFC6FE51CQ39366824-A12C5BFC-F165-4191-913C-0FB687FB068AQ40202703-9C651A6B-7BBC-4CB0-A96B-67F6D6E7C03DQ42257138-03BC3476-1952-49CC-8CEA-2BC6358752A8Q42371169-1C49A8AC-768E-4673-A6FD-801ED25ED0E6Q46177929-7D8D901A-5B2D-49B6-9A46-C72F06472DC5Q47190033-8D668073-ED26-40D0-9AD2-A4BDABCC6970Q47717067-A59D2500-5E8A-462E-A2F0-B385A243C229Q51055337-942BDD04-D304-4909-8A95-B9914D39B76BQ52585080-DCAA350F-31BB-485F-9EBC-8DF5B666F914Q53187098-EE4BD558-D039-46ED-8D53-695D7D723A91Q55081974-681CE712-1F68-4873-A806-CE355415DE15Q55425023-21B4DF73-F121-45B8-AED7-8361A0C384EEQ58711288-AF31B41D-3476-4EDC-B6E9-88647D45DDD8
P2860
The proposed rule for U.S. clinical trial registration and results submission
description
2014 nî lūn-bûn
@nan
2014 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
name
The proposed rule for U.S. clinical trial registration and results submission
@ast
The proposed rule for U.S. clinical trial registration and results submission
@en
type
label
The proposed rule for U.S. clinical trial registration and results submission
@ast
The proposed rule for U.S. clinical trial registration and results submission
@en
prefLabel
The proposed rule for U.S. clinical trial registration and results submission
@ast
The proposed rule for U.S. clinical trial registration and results submission
@en
P2860
P356
P1476
The proposed rule for U.S. clinical trial registration and results submission
@en
P2093
Jerry Sheehan
P2860
P304
P356
10.1056/NEJMSR1414226
P407
P577
2014-12-24T00:00:00Z